News
The Chicago Human Rhythm Project is celebrating 35 years of rhythm, culture and community with Rhythm World, a weeklong ...
The next program of the Rhythm on the River Arts Series in Grand Rapids will be presented by Lake Effect Clarinet Quartet on ...
Rhythm Pharmaceuticals' potential first-in-class HO drug, strong pipeline, and limited competition offer blockbuster potential. Click to read why RYTM is a Buy.
The Winthrop Rhythm & Blues Festival will bring musical talent from all over the globe — and from our own backyard — when it ...
1d
Zacks Investment Research on MSNRYTM Stock Rises on Upbeat Acquired Hypothalamic Obesity Study DataShares of Rhythm Pharmaceuticals RYTM were up 36.6% yesterday after it reported positive top-line data from a phase II study ...
1d
Zacks Investment Research on MSNRhythm Pharmaceuticals (RYTM) Stock Jumps 36.6%: Will It Continue to Soar?Rhythm Pharmaceuticals, Inc. (RYTM) shares rallied 36.6% in the last trading session to close at $89. This move can be attributable to notable volume with a higher number of shares being traded than ...
Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM) (“Rhythm”), a global, commercial-stage biopharmaceutical company dedicated to ...
Rhythm's bivamelagon cut BMI and hunger scores in Phase 2 trial for hypothalamic obesity, prompting plans to discuss Phase 3 ...
Merck & Co. Inc. has strengthened its cardiopulmonary pipeline with its $10 billion acquisition of London-based-Verona Pharma plc. The deal brings Merck Ohtuvayre (ensifentrine) for chronic ...
Shares of US biopharma Rhythm Pharmaceuticals rose 27.4% to $82.96 in early trading today, as it announced positive top-line ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results